tamoxifen and raloxifene for preventing breast cancer

The Nat'l Cancer Institute is now starting a HUGE study to compare tamoxifen and raloxifene for preventing breast cancer.

It's called STAR..."Study of Tamoxifen And Raloxifene."

Tamoxifen (Nolvadex) reduces the risk of breast cancer by almost 50% in high-risk women.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote